The Global Photodynamic Therapy (PDT) market size is expected to reach USD 2,385.5 Million at a revenue CAGR of 8.3% in 2028, according to latest analysis by Emergen Research. Steady market revenue growth can be attributed to rising prevalence of cancer. It has been estimated that there were over 1.8 million new cancer cases diagnosed in the U.S. in 2020 and over 0.6 million people died owing to cancer in 2020.
Photodynamic therapy finds application for treating specific cancer types to improve life span and quality of life of cancer patients. This therapy is gaining increasing popularity as an essential treatment procedure for certain localized cancers. Various photosensitizing drugs are approved by U.S. Food and Drug Administration (FDA) for treatment of pre-cancers/cancers with Porfimer sodium (Photofrin) and Aminolevulinic acid (ALA or Levulan) being the most widely used.
The Photodynamic Therapy research report also includes an insightful study of the prominent players of the industry along with their business overview, strategic planning, and business expansion plans adopted by them. This assists the readers and business owners in formulating strategic expansion and investment plans. The report focuses on mergers and acquisitions, joint ventures, collaborations, partnerships, corporate and government deals, and others. The report also talks about the expansions these prominent players are vying for in the key regions of the market. The report focuses on the detailed analysis of the technological and product developments undertaken by these companies.
The key companies studied in the report are:
Biofrontera AG, LUMIBIRD, Bausch Health Companies Inc., Modulight Corporation, SUS Advancing Technology Co., Ltd., Theralase Technologies Inc., Galderma Laboratories LP, Sun Pharmaceutical Industries Ltd., Hologic Inc., and Quest PharmaTech Inc., Others
On the basis of regional analysis, the market is segmented into the following regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The market is expected to be dominated by North American nations closely followed by European countries. Asia Pacific is expected to show a significant growth owing to recent advancements and rising investments in the R&D sector.
Product Type Outlook (Revenue, USD Million; 2018–2028)
- Photodynamic Therapy Devices
- Photosensitizer Drugs
Disease Outlook (Revenue, USD Million; 2018–2028)
- Actinic Keratosis
- Cancer
- Psoriasis
- Acne
- Others
Application Outlook (Revenue, USD Million; 2018–2028)
- Hospitals
- Specialty Clinics
- Cancer Treatment Centers
- Others
Thank you for reading our report. For any specific details on customization of this report, please get in touch with us. We will ensure the report you get is well-suited to your needs.
